Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Global economic burden of schizophrenia: a systematic review.

Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N.

Neuropsychiatr Dis Treat. 2016 Feb 16;12:357-73. doi: 10.2147/NDT.S96649. eCollection 2016. Review.

2.

Conceptualization and treatment of negative symptoms in schizophrenia.

Sarkar S, Hillner K, Velligan DI.

World J Psychiatry. 2015 Dec 22;5(4):352-61. doi: 10.5498/wjp.v5.i4.352. eCollection 2015 Dec 22.

3.

The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.

Breitborde NJ, Bell EK, Dawley D, Woolverton C, Ceaser A, Waters AC, Dawson SC, Bismark AW, Polsinelli AJ, Bartolomeo L, Simmons J, Bernstein B, Harrison-Monroe P.

BMC Psychiatry. 2015 Oct 28;15:266. doi: 10.1186/s12888-015-0650-3.

4.

Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics.

Bergeson JG, Kalsekar I, Jing Y, You M, Forbes RA, Hebden T.

Am Health Drug Benefits. 2012 Sep;5(6):379-86.

5.

Classification of schizophrenia patients based on resting-state functional network connectivity.

Arbabshirani MR, Kiehl KA, Pearlson GD, Calhoun VD.

Front Neurosci. 2013 Jul 30;7:133. doi: 10.3389/fnins.2013.00133. eCollection 2013.

6.

The cost of schizophrenia in Japan.

Sado M, Inagaki A, Koreki A, Knapp M, Kissane LA, Mimura M, Yoshimura K.

Neuropsychiatr Dis Treat. 2013;9:787-98. doi: 10.2147/NDT.S41632. Epub 2013 May 30.

7.

Yoga for schizophrenia: a systematic review and meta-analysis.

Cramer H, Lauche R, Klose P, Langhorst J, Dobos G.

BMC Psychiatry. 2013 Jan 18;13:32. doi: 10.1186/1471-244X-13-32. Review.

8.

Recovering from hallucinations: a qualitative study of coping with voices hearing of people with schizophrenia in Hong Kong.

Ng P, Chun RW, Tsun A.

ScientificWorldJournal. 2012;2012:232619. doi: 10.1100/2012/232619. Epub 2012 Dec 11.

9.

Brain connectivity networks in schizophrenia underlying resting state functional magnetic resonance imaging.

Yu Q, Allen EA, Sui J, Arbabshirani MR, Pearlson G, Calhoun VD.

Curr Top Med Chem. 2012;12(21):2415-25. Review.

10.
11.

UCSD SORT Test (U-SORT): Examination of a newly developed organizational skills assessment tool for severely mentally ill adults.

Tiznado D, Mausbach BT, Cardenas V, Jeste DV, Patterson TL.

J Nerv Ment Dis. 2010 Dec;198(12):916-9. doi: 10.1097/NMD.0b013e3181fe75b6.

12.

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States.

Furiak NM, Ascher-Svanum H, Klein RW, Smolen LJ, Lawson AH, Conley RR, Culler SD.

Cost Eff Resour Alloc. 2009 Apr 7;7:4. doi: 10.1186/1478-7547-7-4.

14.

The burden of mental disorders.

Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P.

Epidemiol Rev. 2008;30:1-14. doi: 10.1093/epirev/mxn011. Epub 2008 Sep 19. Review.

15.

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study.

Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S, Kyriopoulos I.

Ann Gen Psychiatry. 2008 Aug 28;7:16. doi: 10.1186/1744-859X-7-16.

16.

The evolution of drug development in schizophrenia: past issues and future opportunities.

Carpenter WT, Koenig JI.

Neuropsychopharmacology. 2008 Aug;33(9):2061-79. Epub 2007 Nov 28. Review.

17.

Reducing emergency medical service use in patients with chronic psychotic disorders: results from the FAST intervention study.

Mausbach BT, Cardenas V, McKibbin CL, Jeste DV, Patterson TL.

Behav Res Ther. 2008 Jan;46(1):145-53. Epub 2007 Oct 7.

18.

Performance-based measures of functional skills: usefulness in clinical treatment studies.

Harvey PD, Velligan DI, Bellack AS.

Schizophr Bull. 2007 Sep;33(5):1138-48. Epub 2007 May 9. Review.

19.

Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

Ferreri F, Agbokou C, Gauthier S.

J Psychiatry Neurosci. 2006 Nov;31(6):369-76. Review.

20.

Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.

Karlsson H, Bachmann S, Schröder J, McArthur J, Torrey EF, Yolken RH.

Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4634-9.

Items per page

Supplemental Content

Write to the Help Desk